Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Biochem Cell Biol ; 76: 51-63, 2016 07.
Article in English | MEDLINE | ID: mdl-27113717

ABSTRACT

Bone Morphogenetic Protein (BMP) signal transduction via the canonical Smad158 pathway has previously been linked to dynamin-dependent endocytosis, since the application of chemical inhibitors of clathrin or dynamin in functional cell culture based assays negatively affects initiation and propagation of the Smad response. More recent studies, however, demonstrated efficient Smad signaling by non-internalizable BMP2. The role of endocytosis in BMP signal transduction thus remained controversial. In our study we aimed to refine cell biological assays and to apply novel tools, including a new site-directed fluorescently labeled BMP2 ligand, to revisit key steps in BMP Smad signaling. We found that dynamin2 function was required for BMP2 uptake but was dispensable for C-terminal phosphorylation, nuclear translocation and transcriptional activity of BMP-dependent Smads. Furthermore, we demonstrated a role of dynamin2 in the regulation of steady-state and surface BMP receptor levels, as well as an impact on Smad1 protein level. Thus, dynamin2 allows for modulation of basal and ligand-dependent Smad signaling capacity. High levels of functional dynamin2 enhanced the myogenic differentiation of precursor cells. From our study we conclude that dynamin-dependent endocytosis serves as a regulatory mechanism to fine-tune Smad signaling, but it is not a prerequisite for signal initiation and propagation. Our findings contribute to the understanding of fundamental mechanisms of BMP signaling and thus provide important information for future consideration in the context of therapeutic applications of BMPs.


Subject(s)
Bone Morphogenetic Protein 2/metabolism , Cell Differentiation/physiology , Endocytosis/physiology , Muscle Development/physiology , Signal Transduction/physiology , Smad1 Protein/metabolism , Animals , Bone Morphogenetic Protein 2/genetics , COS Cells , Chlorocebus aethiops , Dynamin II/genetics , Dynamin II/metabolism , Mice , Smad1 Protein/genetics
2.
Mol Biol Cell ; 27(4): 716-30, 2016 Feb 15.
Article in English | MEDLINE | ID: mdl-26739752

ABSTRACT

The expression and function of transforming growth factor-ß superfamily receptors are regulated by multiple molecular mechanisms. The type II BMP receptor (BMPRII) is expressed as two alternatively spliced forms, a long and a short form (BMPRII-LF and -SF, respectively), which differ by an ∼500 amino acid C-terminal extension, unique among TGF-ß superfamily receptors. Whereas this extension was proposed to modulate BMPRII signaling output, its contribution to the regulation of receptor expression was not addressed. To map regulatory determinants of BMPRII expression, we compared synthesis, degradation, distribution, and endocytic trafficking of BMPRII isoforms and mutants. We identified translational regulation of BMPRII expression and the contribution of a 3' terminal coding sequence to this process. BMPRII-LF and -SF differed also in their steady-state levels, kinetics of degradation, intracellular distribution, and internalization rates. A single dileucine signal in the C-terminal extension of BMPRII-LF accounted for its faster clathrin-mediated endocytosis relative to BMPRII-SF, accompanied by mildly faster degradation. Higher expression of BMPRII-SF at the plasma membrane resulted in enhanced activation of Smad signaling, stressing the potential importance of the multilayered regulation of BMPRII expression at the plasma membrane.


Subject(s)
Alternative Splicing , Bone Morphogenetic Protein Receptors, Type II/metabolism , Endocytosis , Protein Biosynthesis , Receptors, Transforming Growth Factor beta/metabolism , Animals , Bone Morphogenetic Protein Receptors, Type II/genetics , COS Cells , Cell Membrane/metabolism , Chlorocebus aethiops , Clathrin-Coated Vesicles/metabolism , Gene Expression Regulation , HEK293 Cells , Humans , Mutation , Protein Isoforms/genetics , Protein Isoforms/metabolism , Proteolysis , Receptors, Transforming Growth Factor beta/genetics , Signal Transduction , Smad Proteins, Receptor-Regulated/metabolism
3.
Biofactors ; 40(2): 171-87, 2014.
Article in English | MEDLINE | ID: mdl-24123658

ABSTRACT

Bone Morphogenetic Proteins (BMPs) are members of the transforming growth factor-ß superfamily of secreted polypeptide growth factors and are important regulators in a multitude of cellular processes. To ensure the precise and balanced propagation of their pleiotropic signaling responses, BMPs and their corresponding signaling pathways are subject to tight control. A large variety of regulatory mechanisms throughout different biological levels combines into a complex network and provides the basis for physiological BMP function. This regulatory network not only includes biochemical factors but also mechanical cues. Both BMP signaling and mechanotransduction pathways are tightly interconnected and represent an elaborate signaling network active during development but also during organ homeostasis. Moreover, its dysregulation is associated with a number of human pathologies. A more detailed understanding of this crosstalk in respect to molecular interactions will be indispensable in the future, in particular to understand BMP-related diseases as well as with regard to an efficient clinical application of BMP ligands.


Subject(s)
Bone Morphogenetic Proteins/physiology , Mechanotransduction, Cellular , Animals , Biomechanical Phenomena , Bone Morphogenetic Protein Receptors/metabolism , Feedback, Physiological , Humans , Protein Transport , Smad Proteins/physiology , Transcriptional Activation
4.
PLoS One ; 6(10): e25163, 2011.
Article in English | MEDLINE | ID: mdl-21998639

ABSTRACT

BACKGROUND: Bone morphogenetic proteins (BMPs) are involved in a plethora of cellular processes in embryonic development and adult tissue homeostasis. Signaling specificity is achieved by dynamic processes involving BMP receptor oligomerization and endocytosis. This allows for spatiotemporal control of Smad dependent and non-Smad pathways. In this study, we investigate the spatiotemporal regulation within the BMP-induced Smad transcriptional pathway. METHODOLOGY/PRINCIPAL FINDINGS: Here we discriminate between Smad signaling events that are dynamin-dependent (i.e., require an intact endocytic pathway) and dynamin-independent. Inhibition of dynamin-dependent endocytosis in fluorescence microscopy and fractionation studies revealed a delay in Smad1/5/8 phosphorylation and nuclear translocation after BMP-2 stimulation of C2C12 cells. Using whole genome microarray and qPCR analysis, we identified two classes of BMP-2 induced genes that are differentially affected by inhibition of endocytosis. Thus, BMP-2 induced gene expression of Id1, Id3, Dlx2 and Hey1 is endocytosis-dependent, whereas BMP-2 induced expression of Id2, Dlx3, Zbtb2 and Krt16 is endocytosis-independent. Furthermore, we demonstrate that short term inhibition of endocytosis interferes with osteoblast differentiation as measured by alkaline phosphatase (ALP) production and qPCR analysis of osteoblast marker gene expression. CONCLUSIONS/SIGNIFICANCE: Our study demonstrates that dynamin-dependent endocytosis is crucial for the concise spatial activation of the BMP-2 induced signaling cascade. Inhibition of endocytic processes during BMP-2 stimulation leads to altered Smad1/5/8 signaling kinetics and results in differential target gene expression. We show that interfering with the BMP-2 induced transcriptional network by endocytosis inhibition results in an attenuation of osteoblast differentiation. This implies that selective sensitivity of gene expression to endocytosis provides an additional mechanism for the cell to respond to BMP in a context specific manner. Moreover, we suggest a novel Smad dependent signal cascade induced by BMP-2, which does not require endocytosis.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Cell Differentiation , Osteoblasts/cytology , Osteoblasts/metabolism , Signal Transduction , Smad Proteins/metabolism , Active Transport, Cell Nucleus/drug effects , Active Transport, Cell Nucleus/genetics , Animals , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Down-Regulation/drug effects , Down-Regulation/genetics , Dynamins/metabolism , Endocytosis/drug effects , Endocytosis/genetics , Extracellular Space/drug effects , Extracellular Space/metabolism , Gene Regulatory Networks/drug effects , Humans , Hydrazones/pharmacology , Kinetics , Mice , Multigene Family/genetics , Oligonucleotide Array Sequence Analysis , Osteoblasts/drug effects , Phosphorylation/drug effects , Phosphorylation/genetics , Signal Transduction/drug effects , Transcription, Genetic/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...